Glenmark Pharmaceuticals Limited (BOM:532296)
1,924.25
-10.50 (-0.54%)
At close: Aug 29, 2025
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 542.93 billion as of August 29, 2025. Its market cap has increased by 28.05% in one year.
Market Cap
542.93B
Enterprise Value
550.60B
Revenue
134.56B
Ranking
n/a
PE Ratio
72.03
Stock Price
1,924.25
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 542.93B, an increase of 47,139.59%. That is a compound annual growth rate of 28.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 29, 2025 | 542.93B | 19.57% |
Dec 31, 2024 | 454.07B | 88.44% |
Dec 29, 2023 | 240.96B | 101.33% |
Dec 30, 2022 | 119.68B | -19.75% |
Dec 31, 2021 | 149.14B | 7.10% |
Dec 31, 2020 | 139.25B | 42.03% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.37T |
HDFC Bank | 14.61T |
Bharti Airtel | 11.33T |
Tata Consultancy Services | 11.16T |
ICICI Bank | 9,981.58B |
State Bank of India | 7,407.57B |
Hindustan Unilever | 6,249.44B |
Infosys | 6,091.89B |